Dasatinib hydrochloride
Cat. No.:YN440046
产品名称: | Dasatinib hydrochloride |
CAS No.: | 854001-07-3 |
Chemical Name: | |
Synonyms: | 达沙替尼盐酸盐; BMS-354825 hydrochloride |
分子量: | 524.47 |
分子式: | C₂₂H₂₇Cl₂N₇O₂S |
SMILES: | O=C(C1=CN=C(S1)NC2=NC(C)=NC(N3CCN(CC3)CCO)=C2)NC4=C(C=CC=C4Cl)C.[H]Cl |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | Dasatinib hydrochloride (BMS-354825 hydrochloride) 是一种具有口服活性的,ATP 竞争性的Src/Bcr-Abl双重抑制剂,对 Src 和 Bcr-Abl 作用的Ki值分别为 16 pM 和 30 pM。Dasatinib hydrochloride 具有有效的抗肿瘤活性。 |
IC50和靶点: | [{name:"Bcr-Abl:1.0 nM (IC50)"},{name: "Src:0.5 nM (IC50)"},{name: "lck:0.4 nM (IC50)"},{name: "Yes:0.5 nM (IC50)"},{name: "c-kit:5.0 nM (IC50)"},{name: "PDGFRβ:28 nM (IC50)"},{name: "p38:100 nM (IC50)"},{name: "Her1:180 nM (IC50)"},{name: "Her2:710 nM (IC50)"},{name: "FGFR-1:880 nM (IC50)"},{name: "MEK:1700 nM (IC50)"}] |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |